ArticlePloS one2011

TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.

Joseph H Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.